Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
99 studies found for:    Open Studies | "Hypercholesterolemia"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Study of Awareness and Detection of Familial Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention:
2 Recruiting Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada
Conditions: Familial Hypercholesterolemia;   Lipid Disorder
Intervention:
3 Recruiting Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia
Conditions: Hypercholesterolemia;   Hyperlipoproteinemia Type II
Interventions: Drug: AEM-28;   Drug: Normal Saline
4 Recruiting Russian Familial Hypercholesterolemia Registry
Condition: Familial Hypercholesterolemia
Intervention:
5 Not yet recruiting French Observatory of Familial Hypercholesterolemia in Cardiology
Condition: Familial Hypercholesterolemia
Intervention:
6 Unknown  Efficacy and Safety of FDC in High Risk Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
Conditions: Hypercholesterolemia;   Dyslipidemia
Interventions: Drug: Rosuvastatin + Ezetimibe;   Drug: Simvastatin + Ezetimibe
7 Recruiting Efficacy Study of Vitamin D and Statins to Treat Hypercholesterolemia
Condition: Primary Hypercholesterolemia
Interventions: Drug: vitamin D3 tablets;   Drug: placebo tablets
8 Unknown  Postprandial Lipid Metabolism in Familial Hypercholesterolaemia:Effects of Fish Oils
Conditions: Hypertriglyceridaemia;   Familial Hypercholesterolaemia
Interventions: Dietary Supplement: Fish oil capsule;   Drug: HMG Coenzyme reductase
9 Unknown  Trial to Assess the Effects of P-OM3 on LDL-C in Subjects With Primary Hypercholesterolemia
Condition: Primary Hypercholesterolemia
Interventions: Drug: P-OM3;   Drug: Placebo
10 Not yet recruiting A Trial to Evaluate the Efficacy of AB-Life Probiotic Product on LDL-Cholesterol Reduction in Moderate Hypercholesterolemia
Condition: Moderate Hypercholesterolemia
Intervention: Dietary Supplement: Probiotics bacterial strains
11 Recruiting The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository
Condition: Homozygous Familial Hypercholesterolemia
Intervention:
12 Recruiting A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia
Condition: Heterozygous Familial Hypercholesterolemia
Interventions: Drug: Bococizumab (PF-04950615;RN316);   Other: Placebo
13 Unknown  Evaluation of Chylomicrons Metabolism in Sub-Clinical Atherosclerosis in Patients Whit Heterozigous Familial Hypercholesterolemia (FH) Treated With Statin Plus Ezetimibe
Condition: Heterozigous Familial Hypercholesterolemia
Intervention: Drug: Statins and Ezetimibe
14 Recruiting Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Conditions: Hypercholesterolemia;   Hypertension
Interventions: Drug: ETC-1002;   Drug: Placebo
15 Recruiting A Study of Evacetrapib (LY2484595) in Japanese Participants With Primary Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: Evacetrapib;   Drug: Placebo
16 Recruiting A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Hypercholesterolemia.
Condition: Hypercholesterolemia
Interventions: Drug: Rosuvastatin;   Drug: Crestor®
17 Not yet recruiting A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese Participants With Primary Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: Evacetrapib;   Drug: Ezetimibe;   Drug: Atorvastatin;   Drug: Placebo
18 Not yet recruiting Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia in South Korea and Taiwan
Condition: Hypercholesterolemia
Interventions: Drug: alirocumab SAR236553/REGN727;   Drug: placebo
19 Recruiting A Study of the Safety and Efficacy of Anacetrapib (MK-0859) Among Participants With Hypercholesterolemia When Added to Ongoing Statin Therapy (MK-0859-022)
Condition: Hypercholesterolemia
Interventions: Drug: Anacetrapib;   Drug: Placebo
20 Recruiting Efficacy/Safety of HCP1306 Tablet Versus HGP0816 Tablet in Patients With Primary Hypercholesterolemia
Condition: Primary Hypercholesterolemia
Interventions: Drug: HGP0816 5mg;   Drug: HGP0816 10mg;   Drug: HGP0816 20mg;   Drug: HCP1306 5/10mg;   Drug: HCP1306 10/10mg;   Drug: HCP1306 20/10mg

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years